| Takeaway | Detail |
|---|---|
| A 72-hour expedited prior authorization delay is only cost-favorable when it prevents a 30-day readmission costing $1,600–$1,900 on average. | Compare the 72-hour expedited delay against the $1,600–$1,900 average excess cost of a 30-day readmission cited for Medicare Advantage. |
| The cost tradeoff applies only when the delayed service is on the plan's own readmission-driver list. | If the service is not a readmission driver for the plan, the $1,600–$1,900 excess readmission cost does not justify accepting the delay. |
| Before accepting any prior authorization delay, verify whether the service maps to an HRRP applicable condition. | HRRP applicable conditions include AMI, HF, pneumonia, COPD, CABG, and THA/TKA. |
| HRRP readmission performance is measured using a hospital-specific excess readmissions ratio for each applicable condition. | Under 42 CFR 412.152, the excess readmissions ratio is the ratio (but not less than 1.0) of risk-adjusted readmissions to expected readmissions for an applicable condition. |
A 72-hour expedited prior authorization delay in Medicare Advantage is only cheaper than a 30-day readmission when the delayed service appears on the plan's readmission-driver list.
That calculation changes when the delayed service maps to an HRRP applicable condition such as AMI, HF, pneumonia, COPD, CABG, or THA/TKA.

How the 72-hour clock and HRRP interact
HRRP is a Medicare value-based purchasing program that adjusts hospital payments based on risk-adjusted excess readmissions for applicable conditions (CMS, Hospital Readmissions Reduction Program page).
The excess readmissions ratio is hospital-specific for each applicable condition and is floored at 1.0 under 42 CFR 412.152. That floor means a hospital at or below its expected readmission rate receives a ratio of 1.0 and no HRRP reduction, while a hospital above baseline receives a ratio above 1.0 and bears the payment reduction. The plan's authorization delay does not itself create an HRRP cost for the plan; the penalty is assessed to the hospital.
| Excess readmissions ratio | HRRP payment effect |
|---|---|
| 1.0 (floor) | No reduction for that condition |
| Above 1.0 | Reduction applies to that hospital-condition pair |
A delayed authorization converts into an HRRP penalty only through the readmission it can set in motion: if the delayed service is part of the care that prevents a 30-day return for an applicable condition, the delay can push a discharge into a readmission that counts in that hospital's condition-specific numerator. The delay does not have to be the sole cause; it only has to be part of the chain that moves an expected non-readmission into an observed readmission for that condition. Because the ratio is risk-adjusted and condition-specific, the same delay can matter for one hospital-condition pair and not another.
Before treating any "expedited" label as a fixed clock, verify the plan's actual expedited-review timeframe in its current prior-authorization policy and the date of that policy. Plan summaries and CMS-facing materials can differ, and the operative timeframe is the one in the policy that governs the case; ask for the policy version, effective date, and exact expedited standard rather than relying on a portal badge or summary sheet.
The practical check is therefore two-part: map the delayed service to an applicable condition for that hospital, then confirm the plan's stated expedited timeframe in the current policy. If the service does not map to an applicable condition, this HRRP channel is not the mechanism at work, even though the readmission cost may still be real. Document both answers in the case file so any later cost comparison uses the same condition and the same clock.

The evidence: readmission costs vs auth delays
Readmissions are not a rounding error in hospital finance. Fierce Healthcare, citing readmission cost analysis, puts additional hospital costs from readmissions at $41.3 billion nationally. That figure is an aggregate scale check: it tells a plan or hospital that readmission cost is large enough to dominate small administrative savings unless the delayed service is tied to a known readmission driver.
The same analysis shows concentration rather than uniformity. Unchecked diabetes led to 23,700 readmissions and $251 million, while chemotherapy complications in the private sector led to 25,500 readmissions and $400 million. Those two examples are not an exhaustive list, but they show that a subset of conditions can generate tens of thousands of readmissions and hundreds of millions of dollars.
| Driver | Readmissions | Additional cost |
|---|---|---|
| Unchecked diabetes | 23,700 | $251 million |
| Chemotherapy complications (private sector) | 25,500 | $400 million |
One-year cost studies comparing readmitted with non-readmitted medical admissions support using the readmission itself as the cost unit. PMC/NCBI notes that when risk-adjusted longer-term costs are otherwise similar, the groups are comparable except for the readmission. That comparability is what allows a cost comparison to treat the readmission as the incremental event rather than assuming the readmitted group was already more expensive.
The practical check is mapping, not assumption. Before accepting a 72-hour expedited prior authorization delay, ask whether the delayed service is on the plan's own readmission-driver list and whether it maps to an HRRP applicable condition. If it does not, the delay's administrative savings are being weighed against a readmission cost that the national figures show is large in aggregate and concentrated in condition-specific drivers; the average excess cost of a 30-day readmission then becomes the relevant comparator, not the authorization's paperwork cost.
Use the national figures as a scale check rather than a patient-level price. A plan should require its own driver list and condition-level readmission counts before treating any delay as cost-neutral, because $41.3 billion nationally is an aggregate and the diabetes and chemotherapy examples show concentration rather than a uniform per-case cost.
Expedited vs standard vs escalation: compared
Checkpoint 3 — weigh the cost of being wrong. Expediting a request that did not require urgency consumes staff time and reviewer attention; that cost is operational and contained. Failing to expedite a heart-failure-related request when the delayed echocardiogram is part of preventing deterioration can contribute to an avoidable readmission, leaving the hospital exposed to the HRRP payment adjustment associated with excess heart-failure readmissions. Because the financial and clinical consequences of a preventable return are asymmetric, the safer default for an HRRP-mapped heart-failure service is to resolve authorization barriers quickly and document the rationale.
Worked Example: Run the Numbers
Illustration inputs (not a real case): On Monday, March 2, 2026, a hospital discharge planner submits an expedited prior authorization request to Medicare Advantage Plan A for post-discharge home health nursing after a beneficiary’s inpatient stay for heart failure. The plan’s expedited decision window runs 72 hours from receipt, making Thursday, March 5, 2026, the decision deadline referenced in the Medicare 72-hour rule discussion cited by Aspirion (August 5, 2026). The parties in this example are the discharging hospital, Plan A, and the beneficiary.
Step 1 — Map the delayed service (illustration): Before accepting any delay, the plan or hospital checks whether the condition driving the requested service appears on the Hospital Readmissions Reduction Program (HRRP) applicable-condition list described by CMS. In this example, heart failure is on that list, so the delayed service is treated as a readmission-driver exposure. This step is a classification check only; it does not restate how HRRP payment adjustments work.
Step 2 — Compare costs with the article’s illustrative arithmetic: If 100 delayed requests produce about 2 extra readmissions and the excess readmission cost is $1,600–$1,900, the expected extra cost is $3,200–$3,800, or $32–$38 per delayed authorization. Before using that comparator for a specific plan, verify the plan’s current expedited-review policy and the hospital’s condition-specific excess readmissions ratio.
Step 3 — Apply the decision rule: For this example, the delayed service maps to an HRRP applicable condition, so the default is to seek expedited review unless the plan’s documented, member-specific data show a materially lower readmission risk. Confirm the plan’s current expedited-review time frame and the hospital’s condition-specific excess readmissions ratio before treating any delay as cost-favorable; use the arithmetic above as the comparator.
Decision rules for 2026 PA delays
This section provides the if/then rule set that operationalizes the canonical rule for 2026 Medicare Advantage prior authorization delays, including a skip-and-document discipline borrowed from the site’s STR-chimerism pattern: when you deviate from the default path, record the clinical reason, the decision, and the timestamped evidence in the same workflow. Before accepting any delay, confirm whether the requested service treats a condition on the Hospital Readmissions Reduction Program (HRRP) applicable-condition list published by the Centers for Medicare & Medicaid Services (CMS). That mapping check is the decision gate; the sections on mechanism, cost evidence, and pathway comparison handle the why and the tradeoffs.
IF the delayed service treats an HRRP applicable condition—acute myocardial infarction, heart failure, pneumonia, chronic obstructive pulmonary disease, coronary artery bypass graft surgery, or elective primary total hip arthroplasty/total knee arthroplasty (AMI, HF, pneumonia, COPD, CABG, THA/TKA)—THEN request expedited review the same day and document the clinical justification. The documentation packet should name the applicable condition, the specific service under review, the clinical risk of postponement, the ordering clinician, and the date and time the expedited request was submitted. Treat “expedited” as a distinct request path under Medicare Advantage rules (Aspirion notes Medicare’s 72-hour rule in the context of readmission-related reviews) and keep the submission record with the authorization file.
IF the service has no HRRP-condition linkage, THEN accept standard turnaround but log the request date and approval date to build an internal delay-to-readmission audit trail. At minimum, capture the member identifier used by your plan workflow, the service category, the plan’s decision, and any rescheduling caused by the delay. This log is not a substitute for clinical judgment; it is the dataset that lets a utilization or quality team test whether routine delays cluster before unplanned returns for services outside the HRRP list.
IF a delay results in a denial or an adverse outcome, THEN file a redetermination request immediately. In Medicare Advantage, denials begin at the plan level, so the first action is to submit the plan’s redetermination with the clinical record that supports medical necessity and the timeline showing when the authorization was requested, delayed, and decided. Because appeal steps and deadlines can vary by notice type and plan process, verify the exact filing instructions on the denial notice and retain proof of submission.
Apply the skip-and-document pattern in every branch: approve-and-wait, expedite, or appeal. A complete record makes the 2026 prior authorization decision auditable and prevents the team from reconstructing rationale after a readmission, denial, or grievance review.
What to do next
| Step | Action | Why it matters |
|---|---|---|
| 1 | Identify the exact service under prior authorization and check whether it maps to an HRRP applicable condition (AMI, HF, pneumonia, COPD, CABG, or THA/TKA). | This is the decision point: HRRP-mapped services carry 30-day readmission risk that can justify escalation, while non-mapped services do not. |
| 2 | If the service maps to an HRRP applicable condition, request an expedited review from your Medicare Advantage plan the same day. | Expedited review targets the 72-hour window shown above, reducing the chance that a delay contributes to a preventable readmission. |
| 3 | Ask the plan whether the delayed service is on its own readmission-driver list and compare the expedited delay against the average excess 30-day readmission cost figures shown above. | The cost tradeoff only applies when the service is a plan-specific readmission driver; otherwise, accepting the delay may not prevent the excess readmission costs cited above. |
| 4 | If the service does not map to an HRRP applicable condition and is not a plan readmission driver, accept the standard prior authorization turnaround. | When the service is not tied to HRRP readmission measures, a standard delay is defensible and escalation is unlikely to change clinical or cost outcomes. |
| 5 | Document the prior authorization request, the HRRP condition mapping (if applicable), and the clinical reason for urgency in the plan’s official coverage determination record. | Clear documentation supports expedited handling and creates a record if the plan’s decision affects hospital-specific excess readmission performance. |
| 6 | If expedited review is denied for an HRRP-mapped service, file an appeal or reconsideration through the Medicare Advantage plan’s official appeals process immediately. | A timely appeal preserves your right to challenge a delay that could increase 30-day readmission risk for an HRRP-measured condition. |
Frequently Asked Questions
If a prior authorization delay for a service not on the plan's readmission-driver list is accepted, what happens to the cost comparison?
The $1,600–$1,900 excess readmission cost does not justify accepting the delay because the cost tradeoff only applies when the delayed service is on the plan's own readmission-driver list.
Which conditions are considered HRRP applicable conditions that trigger the readmission-cost comparison?
HRRP applicable conditions include AMI, HF, pneumonia, COPD, CABG, and THA/TKA.
How is HRRP readmission performance measured for each applicable condition?
HRRP readmission performance is measured using a hospital-specific excess readmissions ratio for each applicable condition.
Under 42 CFR 412.152, how is the excess readmissions ratio defined?
The excess readmissions ratio is the ratio (but not less than 1.0) of risk-adjusted readmissions to expected readmissions for an applicable condition.
What happens if a delayed service maps to an HRRP applicable condition but the plan has not yet implemented its own readmission-driver list?
The $1,600–$1,900 excess readmission cost does not justify accepting the delay because the cost tradeoff only applies when the delayed service appears on the plan's readmission-driver list.
Is a 72-hour expedited prior authorization delay always cost-favorable under Medicare Advantage?
No — it is only cost-favorable when it prevents a 30-day readmission costing $1,600–$1,900 on average, and only when the delayed service is on the plan's readmission-driver list.
Quick answers
| When is a 72-hour expedited prior authorization delay cost-favorable in Medicare Advantage? | A 72-hour expedited prior authorization delay is only cost-favorable when it prevents a 30-day readmission costing the average excess amount cited for Medicare Advantage and the delayed service appears on the plan's own readmission-driver list. |
| What should be verified before accepting any prior authorization delay? | Before accepting any prior authorization delay, verify whether the service maps to an HRRP applicable condition. |
| Which conditions are included as HRRP applicable conditions? | HRRP applicable conditions include AMI, HF, pneumonia, COPD, CABG, and THA/TKA. |
| How is HRRP readmission performance measured? | HRRP readmission performance is measured using a hospital-specific excess readmissions ratio for each applicable condition. |
| How does 42 CFR 412.152 define the excess readmissions ratio? | Under 42 CFR 412.152, the excess readmissions ratio is the ratio (but not less than 1.0) of risk-adjusted readmissions to expected readmissions for an applicable condition. |
Also worth reading: Hospital cost containment: prior auth delays, readmission risk, denials: Hospital cost containment: prior auth · Veteran suicide data gaps: 6,488 deaths vs incomplete Veterans Affairs care, 2026: Veteran suicide data gaps: 6,488 · Wegovy and Medicare in 2026: How the $2,100 Part D Cap Affects Access: Wegovy and Medicare in 2026: